Literature DB >> 27085812

Cerebellum Development and Tumorigenesis: A p53-Centric Perspective.

Nicolas J Barthelery1, James J Manfredi2.   

Abstract

The p53 protein has been extensively studied for its role in suppressing tumorigenesis, in part through surveillance and maintenance of genomic stability. p53 has been associated with the induction of a variety of cellular outcomes including cell cycle arrest, senescence, and apoptosis. This occurs primarily, but not exclusively, through transcriptional activation of specific target genes. By contrast, the participation of p53 in normal developmental processes has been largely understudied. This review focuses on possible functions of p53 in cerebellar development. It can be argued that a better understanding of such mechanisms will provide needed insight into the genesis of certain embryonic cancers including medulloblastomas, and thus lead to more effective therapies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Sonic Hedgehog pathway; cerebellum development; medulloblastomas; p53

Mesh:

Substances:

Year:  2016        PMID: 27085812      PMCID: PMC4853753          DOI: 10.1016/j.molmed.2016.03.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  72 in total

1.  Hedgehog controls neural stem cells through p53-independent regulation of Nanog.

Authors:  Agnese Po; Elisabetta Ferretti; Evelina Miele; Enrico De Smaele; Arianna Paganelli; Gianluca Canettieri; Sonia Coni; Lucia Di Marcotullio; Mauro Biffoni; Luca Massimi; Concezio Di Rocco; Isabella Screpanti; Alberto Gulino
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 2.  Roles for Hedgehog signaling in adult organ homeostasis and repair.

Authors:  Ralitsa Petrova; Alexandra L Joyner
Journal:  Development       Date:  2014-09       Impact factor: 6.868

3.  p53: the barrier to cancer stem cell formation.

Authors:  Ronit Aloni-Grinstein; Yoav Shetzer; Tom Kaufman; Varda Rotter
Journal:  FEBS Lett       Date:  2014-02-19       Impact factor: 4.124

4.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

5.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

6.  Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.

Authors:  Yoshinori Abe; Eri Oda-Sato; Kei Tobiume; Keiko Kawauchi; Yoichi Taya; Koji Okamoto; Moshe Oren; Nobuyuki Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-21       Impact factor: 11.205

7.  p53 regulates hematopoietic stem cell quiescence.

Authors:  Yan Liu; Shannon E Elf; Yasuhiko Miyata; Goro Sashida; Yuhui Liu; Gang Huang; Silvana Di Giandomenico; Jennifer M Lee; Anthony Deblasio; Silvia Menendez; Jack Antipin; Boris Reva; Andrew Koff; Stephen D Nimer
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

8.  p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.

Authors:  Abhinav K Jain; Kendra Allton; Michelina Iacovino; Elisabeth Mahen; Robert J Milczarek; Thomas P Zwaka; Michael Kyba; Michelle Craig Barton
Journal:  PLoS Biol       Date:  2012-02-28       Impact factor: 8.029

9.  Regulation of p53 stability and apoptosis by a ROR agonist.

Authors:  Yongjun Wang; Laura A Solt; Douglas J Kojetin; Thomas P Burris
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

Authors:  Alina Molchadsky; Igor Shats; Naomi Goldfinger; Meirav Pevsner-Fischer; Melissa Olson; Ariel Rinon; Eldad Tzahor; Guillermina Lozano; Dov Zipori; Rachel Sarig; Varda Rotter
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

View more
  3 in total

1.  A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

Authors:  Heather E Olson; Nolwenn Jean-Marçais; Edward Yang; Delphine Heron; Katrina Tatton-Brown; Paul A van der Zwaag; Emilia K Bijlsma; Bryan L Krock; E Backer; Erik-Jan Kamsteeg; Margje Sinnema; Margot R F Reijnders; David Bearden; Amber Begtrup; Aida Telegrafi; Roelineke J Lunsing; Lydie Burglen; Gaetan Lesca; Megan T Cho; Lacey A Smith; Beth R Sheidley; Christelle Moufawad El Achkar; Phillip L Pearl; Annapurna Poduri; Cara M Skraban; Jennifer Tarpinian; Addie I Nesbitt; Dietje E Fransen van de Putte; Claudia A L Ruivenkamp; Patrick Rump; Nicolas Chatron; Isabelle Sabatier; Julitta De Bellescize; Laurent Guibaud; David A Sweetser; Jessica L Waxler; Klaas J Wierenga; Jean Donadieu; Vinodh Narayanan; Keri M Ramsey; Caroline Nava; Jean-Baptiste Rivière; Antonio Vitobello; Frédéric Tran Mau-Them; Christophe Philippe; Ange-Line Bruel; Yannis Duffourd; Laurel Thomas; Stefan H Lelieveld; Janneke Schuurs-Hoeijmakers; Han G Brunner; Boris Keren; Julien Thevenon; Laurence Faivre; Gary Thomas; Christel Thauvin-Robinet
Journal:  Am J Hum Genet       Date:  2018-04-12       Impact factor: 11.025

2.  Mouse models and strain-dependency of Chédiak-Higashi syndrome-associated neurologic dysfunction.

Authors:  Adam Hedberg-Buenz; Laura M Dutca; Demelza R Larson; Kacie J Meyer; Dana A Soukup; Carly J van der Heide; Hannah E Mercer; Kai Wang; Michael G Anderson
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

3.  Sox2+ cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence.

Authors:  Daniel M Treisman; Yinghua Li; Brianna R Pierce; Chaoyang Li; Andrew P Chervenak; Gerald J Tomasek; Guillermina Lozano; Xiaoyan Zheng; Marcel Kool; Yuan Zhu
Journal:  Neurooncol Adv       Date:  2019-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.